These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11429224)

  • 21. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
    Peng H; Chen L; Guo R; Zhang Y; Li WF; Mao YP; Sun Y; Zhang F; Liu LZ; Tian L; Ma J
    Chin J Cancer; 2017 Mar; 36(1):32. PubMed ID: 28340596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
    Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
    Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of brachytherapy in early-stage nasopharyngeal carcinoma.
    Chang JT; See LC; Tang SG; Lee SP; Wang CC; Hong JH
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1019-24. PubMed ID: 8985022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
    Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
    Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
    Levendag PC; Schmitz PI; Jansen PP; Eijkenboom WM; Visser AG; Kolkman-Deurloo IK; Sipkema D; Visch LL; Senan S
    J Clin Oncol; 1998 Jun; 16(6):2213-20. PubMed ID: 9626223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
    Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
    Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma.
    Chen JZ; Le QT; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Cui NJ; Zhao C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):929-34. PubMed ID: 22975606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
    Leung WM; Tsang NM; Chang FT; Lo CJ
    Head Neck; 2005 Mar; 27(3):187-94. PubMed ID: 15627248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term efficacy of prophylactic upper neck irradiation for stage N0 nasopharyngeal carcinoma].
    Chen CZ; Li DR; Chen ZJ; Li DS; Guo LJ; Guo H
    Ai Zheng; 2008 Mar; 27(3):295-8. PubMed ID: 18334120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
    Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis.
    Chua DT; Sham JS; Au GK; Choy D
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):334-43. PubMed ID: 12023137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis.
    Chen FP; Zhou GQ; Qi ZY; Lin L; Hu J; Wang XJ; Sun Y
    PLoS One; 2017; 12(5):e0176995. PubMed ID: 28489930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
    BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Observation on effect of radiotherapy and antike capsule combination therapy in treating nasopharyngeal cancer patients].
    Xie FY; Huang HY; Hu JZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Dec; 21(12):888-90. PubMed ID: 12575586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.